Polypharmacy and specific comorbidities in university primary care settings-Reference-Cited by-同舟云学术

Polypharmacy and specific comorbidities in university primary care settings

Published:2016-11 Issue: Volume:35 Page:35-42
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Aubert Carole E.,Streit Sven,Da Costa Bruno R.,Collet Tinh-Hai,Cornuz Jacques,Gaspoz Jean-Michel,Bauer Doug,Aujesky Drahomir,Rodondi Nicolas

Funder

Swiss National Science Foundation

European Commission (EC) HORIZON 2020

Swiss State Secretariat for Education, Research and Innovation (SERI)

Swiss University Conference and the State Secretariat for Education, Research and Innovation

Publisher

Elsevier BV

Subject

Internal Medicine

Reference54 articles.

1. WHO methods for life expectancy and healthy life expectancy;World Health Organisation;Global health estimates technical paper WHO/HIS/HSI/GHE/2014.5,2014

2. Age- and gender-related prevalence of multimorbidity in primary care: the Swiss FIRE project;Rizza;BMC Fam Pract,2012

3. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study;Barnett;Lancet,2012

4. Temporal trends in polypharmacy and hyperpolypharmacy in older New Zealanders over a 9-year period: 2005-2013;Nishtala;Gerontology,2015

5. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance;Boyd;JAMA,2005

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of cardiovascular drug-related adverse drug reactions consultations in UK primary care: A cross-sectional study;PLOS ONE;2024-07-24

2. Defining, identifying and addressing problematic polypharmacy within multimorbidity in primary care: a scoping review;BMJ Open;2024-05

3. Influence of chronic medical conditions on older patients’ willingness to deprescribe medications: a cross-sectional study;BMC Geriatrics;2024-04-04

4. Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review;The Lancet Healthy Longevity;2024-04

5. Polypharmacy in chronic kidney disease: Health outcomes & pharmacy-based strategies to mitigate inappropriate polypharmacy;The American Journal of the Medical Sciences;2024-01